Michael W. Beck, PhD
banner
beckchemistry.bsky.social
Michael W. Beck, PhD
@beckchemistry.bsky.social
Biochemist, chemical biologist, medicinal chemist, bioinorganic chemist, & pilot. Asst. Prof. at Eastern Illinois University Department of Chemistry and Biochemistry
This work was carried out by 6
@weareeiu.bsky.social students including @emmanuel-adusah.bsky.social #PUI #proudPI
July 15, 2025 at 5:39 PM
Our work serves as a crucial reminder to always thoroughly validate your #chemicaltools within each specific experimental context. Assuming specificity, as often happens with FDA for CES2 can lead to misinterpretations. Read the paper at: www.sciencedirect.com/science/arti...
www.sciencedirect.com
July 15, 2025 at 5:39 PM
We also demonstrate that FDA may be suitable for studying CES2 when CES2 is the primary hydrolase, such as overexpression models.
July 15, 2025 at 5:39 PM
Many researchers currently use FDA to study CES2, without the necessary validation. Our work shows that while FDA prefers CES2 over CES1 in vitro, it doesn't specifically report on CES2 in complex biological systems like HepG2 cells, where other #hydrolases can interfere.
July 15, 2025 at 5:39 PM
NSF addresses this in the broader impacts evaluation of grant applications. Adapting the proposed work/a portion of the work to an outreach project is a common approach to demonstrate broader impacts and can have a portion of the budget associated with it.
February 17, 2025 at 3:52 PM
Just got the same error when using Login.gov to log in
February 3, 2025 at 7:53 PM
I may have some interested students
January 28, 2025 at 5:10 AM